0001415889-24-014573.txt : 20240524
0001415889-24-014573.hdr.sgml : 20240524
20240524185650
ACCESSION NUMBER: 0001415889-24-014573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240524
FILED AS OF DATE: 20240524
DATE AS OF CHANGE: 20240524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Panzara Michael A.
CENTRAL INDEX KEY: 0001679039
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39503
FILM NUMBER: 24985902
MAIL ADDRESS:
STREET 1: 733 CONCORD AVENUE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athira Pharma, Inc.
CENTRAL INDEX KEY: 0001620463
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 453368487
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: (425) 620-8501
MAIL ADDRESS:
STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104
CITY: BOTHELL
STATE: WA
ZIP: 98011
FORMER COMPANY:
FORMER CONFORMED NAME: M3 Biotechnology, Inc.
DATE OF NAME CHANGE: 20140924
4
1
form4-05242024_100543.xml
X0508
4
2024-05-24
0001620463
Athira Pharma, Inc.
ATHA
0001679039
Panzara Michael A.
C/O ATHIRA PHARMA, INC.
18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL
WA
98011
true
false
false
false
0
Stock Option (Right to Buy)
2.64
2024-05-24
4
A
0
20900
0
A
2034-05-23
Common Stock
20900
20900
D
The shares subject to the option will vest on the earlier of (i) May 24, 2025, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 24, 2024. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.
/s/ Mark Worthington, Attorney in fact for Michael A. Panzara
2024-05-24